Autoimmune hepatitis Diagnostic of choice: Difference between revisions
Jump to navigation
Jump to search
| Line 5: | Line 5: | ||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
=== Gold standard/Study of choice: === | === Gold standard/Study of choice: === | ||
*[[Liver biopsy]] is the gold standard test for the diagnosis of [[autoimmune hepatitis]]<ref name="pmid12362575">{{cite journal |vauthors=Carpenter HA, Czaja AJ |title=The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants |journal=Clin Liver Dis |volume=6 |issue=3 |pages=685–705 |year=2002 |pmid=12362575 |doi= |url=}}</ref><ref name="pmid17051746">{{cite journal |vauthors=Szabó Z |title=[The role of liver biopsy in the diagnosis of autoimmune hepatitis] |language=Hungarian |journal=Orv Hetil |volume=147 |issue=35 |pages=1697–702 |year=2006 |pmid=17051746 |doi= |url=}}</ref> | *[[Liver biopsy]] is the gold standard test for the diagnosis of [[autoimmune hepatitis]]<ref name="pmid12362575">{{cite journal |vauthors=Carpenter HA, Czaja AJ |title=The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants |journal=Clin Liver Dis |volume=6 |issue=3 |pages=685–705 |year=2002 |pmid=12362575 |doi= |url=}}</ref><ref name="pmid17051746">{{cite journal |vauthors=Szabó Z |title=[The role of liver biopsy in the diagnosis of autoimmune hepatitis] |language=Hungarian |journal=Orv Hetil |volume=147 |issue=35 |pages=1697–702 |year=2006 |pmid=17051746 |doi= |url=}}</ref><ref name="pmid21674554">{{cite journal |vauthors=Suzuki A, Brunt EM, Kleiner DE, Miquel R, Smyrk TC, Andrade RJ, Lucena MI, Castiella A, Lindor K, Björnsson E |title=The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury |journal=Hepatology |volume=54 |issue=3 |pages=931–9 |year=2011 |pmid=21674554 |pmc=3192933 |doi=10.1002/hep.24481 |url=}}</ref> | ||
*Liver biopsy is performed by following methods: | *Liver biopsy is performed by following methods: | ||
**Percutaneous liver biopsy with or without [[ultrasound]] guidance | **Percutaneous liver biopsy with or without [[ultrasound]] guidance | ||
Revision as of 03:34, 31 December 2017
|
Autoimmune hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Autoimmune hepatitis Diagnostic of choice On the Web |
|
American Roentgen Ray Society Images of Autoimmune hepatitis Diagnostic of choice |
|
Risk calculators and risk factors for Autoimmune hepatitis Diagnostic of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Manpreet Kaur, MD [2]
Overview
Diagnostic Study of Choice
Gold standard/Study of choice:
- Liver biopsy is the gold standard test for the diagnosis of autoimmune hepatitis[1][2][3]
- Liver biopsy is performed by following methods:
- Percutaneous liver biopsy with or without ultrasound guidance
- Transjugular liver biopsy
Histology findings usually found on biopsy:
- Interface hepatitis (ie, piecemeal necrosis) is the histological hallmark
- Portal lesion spares the biliary tree
- This involves most of the lobule
- Lobular collapse which is best identified by reticulin staining
- There is lymphoplasmacytic periportal infiltrate which invade the limiting plate
- There is an abundance of plasma cells and eosinophils are usually present
- A plasma cell infiltrate lead to plasma cell hepatitis If it involves lobules called lobular or whole liver known as panacinar hepatitis
In cirrhosisfollowing findings are seen on biopsy:
Overlap syndrome
Liver biospy is gold standard for diagnosing overlap syndrome[4][5]
| Histology findings of overlap syndrome | |
|---|---|
| Types | Biopsy findings |
| AIH-PBC |
|
| AIH-PSC |
|
| AIH-cholestatic syndrome |
|
References
- ↑ Carpenter HA, Czaja AJ (2002). "The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants". Clin Liver Dis. 6 (3): 685–705. PMID 12362575.
- ↑ Szabó Z (2006). "[The role of liver biopsy in the diagnosis of autoimmune hepatitis]". Orv Hetil (in Hungarian). 147 (35): 1697–702. PMID 17051746.
- ↑ Suzuki A, Brunt EM, Kleiner DE, Miquel R, Smyrk TC, Andrade RJ, Lucena MI, Castiella A, Lindor K, Björnsson E (2011). "The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury". Hepatology. 54 (3): 931–9. doi:10.1002/hep.24481. PMC 3192933. PMID 21674554.
- ↑ Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ (2010). "Diagnosis and management of primary sclerosing cholangitis". Hepatology. 51 (2): 660–78. doi:10.1002/hep.23294. PMID 20101749.
- ↑ Dienes HP, Erberich H, Dries V, Schirmacher P, Lohse A (2002). "Autoimmune hepatitis and overlap syndromes". Clin Liver Dis. 6 (2): 349–62, vi. PMID 12122860.